Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2064]
News [3528]
Articles [160]
Editorials [3]
Conferences [127]
elearning [18]

The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues

ECCO 15 - ESMO 34
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )
22 Jul 2009

ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?

Why attend ECCO 15 - ESMO 34?
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )
22 Jul 2009

Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma

Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma ( Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA )
2 Jul 2009

Bortezomib based therapies for myeloma

Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute
Bortezomib based therapies for myeloma ( Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute )
2 Jul 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009

AACR 2009: Cancer stem cells and leukaemia

Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009

Myelodysplastic syndromes (MDS)

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Myelodysplastic syndromes (MDS) ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

Innovation in the treatment of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Innovation in the treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

Epigenetics of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Epigenetics of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

Benefits of azacitidine for treatment of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Benefits of azacitidine for treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia

Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation